Please login to the form below
U300
This page shows the latest U300 news and features for those working in and with pharma, biotech and healthcare.
Lilly signs $570m deal for next-gen Humalog
Meanwhile, a BioChaperone version of the U200 formulation is also in the pipeline, along with an even higher (U300) dose, according to Adocia and Lilly.
Latest news
-
Lantus faces first biosimilar rival in Europe
Meanwhile, Sanofi has not been resting on its laurels and has already filed for approval of a Lantus follow-up called Toujeo (formerly U300) which promises an improved pharmacodynamic profile with
-
FDA to review Sanofi's Lantus successor
The regulator will now spend the next few months assessing the safety and efficacy of Toujeo, formerly known as U300, which is a concentrated version of Lantus that has demonstrated an
-
ADA: Novo says switching to Tresiba could reduce NHS costs
formerly U300) is able to reduce rates of hypoglycaemia compared to Lantus as well as having less weight gain.
-
Merck joins biosimilar Lantus race
The French company is hoping to be able to bring its Lantus follow-up U300 - which promises to have less potential to cause hypoglycaemia than its parent product - before it loses
-
Sanofi has been light on product launches, says CEO
Sanofi is firmly focused on bringing a safer version of Lantus called U300 to market before it loses market exclusivity for its top-seller, and R&D chief Elias Zerhouni said
More from news
Approximately 3 fully matching, plus 8 partially matching documents found.
Featured jobs
- Sudler London - Senior Medical Writer
-
Competitive
- Account Director, Healthcare Communications Agency
-
£54, 000- £60, 000
- Head of Market Access - International - Based Cambridge
-
Excellent Basic, Bonus and Flex Benefits
- Senior/ Market Access Consultant, UK, HOME BASED, £50-60K
-
Excellent package
- Senior Medical Writer, MedComms Agency
-
£40 - 55, 000 according to skills and experience benefits
- Science Writer, Healthcare Advertising Agency
-
£40, 000 - 45, 000 DOE benefits,
- Principal Medical Writer / Editorial Director – Medical Communic...
-
£60, 000 - £80, 000
-
Healthcare PR Senior Account Manager
-
Salary TBC
- Senior Medical Writer, Principal Medical Writer, Scientific Dire...
-
£40000 - £75000 Bonus Benefits
- Account Director or Senior Account Director
-
Salary TBC
- Senior Writer, Healthcare Advertising, London
-
Excellent package
- Account Manager, Healthcare Advertising
-
£30 - 38, 000 (or -)
- Senior Strategist/ Planner, Healthcare Marketing, London
-
Excellent package
- Medical Writers Required - Hertfordshire
-
Competitive
- Account Director, Medical Communications & Events
-
£50 - 65, 000 according to skills and experience benefits
-
Systematic Review Lead- London
-
Negotiable
- Technical Manager – Developer and Commercial Excellence, Healthc...
-
Excellent package
Subscribe to our email news alerts
- Tox trouble stalls Sosei/Allergan Alzheimer’s drug
- London cancer hub launched by Cancer Research UK
- Rival Opdivo rejected, Novartis combo gets NICE green light in adjuvant melanoma
- Making a Difference - The Future of Pharma
- AZ prepares to file COPD triple, taking on rival GSK
- Controversy grows around GP at Hand service after minister’s endorsement
PMHub
Star
We're passionate about helping our clients to make a real commercial impact. We achieve this through our unique approach to...
Latest intelligence
- PM Society Digital Awards – the power of together
- Our chief executive, Emma Statham, writes about the value of awards and the power of together....
- Seduce anyone in four simple steps
- You know the health of the global economy is dependent on our ability to seduce one another – don’t you? And you know that we need to be able to...
- What Would Jeremy Do? : Assessing the impact of a Corbyn-led Labour government
- GK Strategy are delighted to announce the launch our latest briefing paper entitled ‘What Would Jeremy Do? Assessing the impact of a Corbyn-led Labour government’....
Quick links
Infographics
